Search Results
Results found for "Glenn S. Vraniak"
Posts (67)
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial Officer (CFO), effective immediately. Mr. Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company
- Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
Here we report that neuropeptide S (NPS) signaling in the PVT is necessary for stimulus salience encoding
- Dr. Alexander S. Hauser receives the Bachem award for peptide science
November 2021 Read more at the source #DrGPCR #GPCR #IndustryNews
Other Pages (199)
- Tanishka S. Saraf | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Tanishka S. Saraf About Tanishka S. neurobiology of neuropsychiatric disorders and to develop safe and effective treatments. " Tanishka S.
- Dr. Alexander S. Hauser | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Dr. Alexander S. Hauser About Dr. Alexander S. Alexander S.
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Dr. Roger Sunahara About Dr. G protein splice forms, specifically the short and long forms of the stimulatory G protein, Galpha-s( s) and Galpha-s(l), respectively. We demonstrated that Galpha-s(l), but not Galpha-s(s), regulates extracellularly regulated kinases (ERK We speculate that these aberrations in Galpha-s(l), specifically, may be involved in other pathologies
